Moderna stock downgrade: Openheimer analyst discusses why he downgraded the stock to neutral

Hartaj Singh, Oppenheimer Analyst, joins Yahoo Finance to discuss downgrading Moderna earlier this month, future outlook on the stock, and questions around booster shots.